Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Beyond migraine: CGRP inhibition at the neurovascular interface and its implications for glaucoma risk.
Journal: Expert review of clinical pharmacology
Published: August 10, 2026
Adoption of Bevacizumab Biosimilars in Medicare Part B: Socioeconomic and Geographic Variation, 2019-2023.
Journal: JCO oncology practice
Published: July 07, 2026
RANKL Inhibition and the Risk of Ocular Hypertension and Primary Open-Angle Glaucoma.
Journal: Investigative ophthalmology & visual science
Published: June 04, 2026
Relationship Between Omega-3 Fatty Acids and Glaucoma Risk in Patients With Dry Eye Disease: A Multinational Retrospective Cohort Study.
Journal: Translational vision science & technology
Published: June 01, 2026
Association Between PCSK9 Inhibitor Use and Risk of Age-Related Macular Degeneration.
Journal: Translational vision science & technology
Published: May 29, 2026
Risk of glaucoma among patients using tadalafil for lower urinary tract symptoms: a multinational cohort study.
Journal: The British journal of ophthalmology
Published: March 23, 2026
Association between probiotic prescriptions and the incidence of primary open-angle glaucoma in patients with documented dry eye.
Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: February 23, 2026
Visual Impairment as a Marker of Systemic Vulnerability and Cause-Specific Mortality in U.S. Adults.
Visual Impairment as a Marker of Systemic Vulnerability and Cause-Specific Mortality in U.S. Adults.
Journal: American journal of ophthalmology
Published: February 17, 2026
Hypothyroidism and Risk of Inflammatory Bowel Disease: Influence of Age and Race in a Global Cohort.
Hypothyroidism and Risk of Inflammatory Bowel Disease: Influence of Age and Race in a Global Cohort.
Journal: Rhode Island medical journal (2013)
Published: January 27, 2026
GLP-1 receptor agonists and age-related macular degeneration risk in diabetes or non-diabetic obesity: A retrospective cohort study.
Journal: The American journal of medicine
Published: January 03, 2026
Last Updated: 09/26/2026